Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by R. Veillon
MA04.03 Immunotherapy for Non-Small Cell Lung Cancers (NSCLC) With Oncogenic Driver Mutations: New Results From the Global IMMUNOTARGET Registry
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
OA12.01 Phase II Data for the MET Inhibitor Tepotinib in Patients With Advanced NSCLC and MET Exon 14-Skipping Mutations
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Related publications
Hot Spot Mutations in Finnish Non-Small Cell Lung Cancers
Lung Cancer
Cancer Research
Oncology
Respiratory Medicine
Pulmonary
New Driver Mutations Detected in NSCLC
Cancer Discovery
Oncology
TG4010 Immunotherapy Combined With First-Line Therapy in Advanced Non-Small Cell Lung Cancer (NSCLC): Phase IIb Results of the TIME Study
Journal for ImmunoTherapy of Cancer
Oncology
Molecular Medicine
Pharmacology
Cancer Research
Allergy
Immunology
P2.04-29 Preliminary Results With Tislelizumab in Chinese Patients With Non-Small Cell Lung Cancer (NSCLC)
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
P3.01-13 Prognosis of Non-Driver, Never Smoker Metastatic Non-Small Lung Cancer (NSCLC)
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
FDA Approves Breakthrough Immunotherapy for Patients With Non-Small-Cell Lung Cancer
Cancer
Cancer Research
Oncology
P1.01-53 Bone Metastases and Efficacy of Immunotherapy in Patients With Pretreated Advanced Non-Small-Cell Lung Cancer (NSCLC)
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Quantifying the Benefit of Non-Small-Cell Lung Cancer Immunotherapy
The Lancet
Medicine
PCN134 Patient Preferences for Non-Small Cell Lung Cancer (NSCLC) Treatments
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental